The Paediatric Virtual Autopsy Trial
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01888380 |
Recruitment Status :
Completed
First Posted : June 27, 2013
Last Update Posted : January 11, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
In light of declining autopsy rates around the world, post-mortem MR imaging is a promising alternative to conventional autopsy in the investigation of infant death. A major drawback of this non-invasive autopsy approach is the fact that histopathological and microbiological examination of the tissue is not possible. The objective of this prospective study is to compare the performance of minimally invasive, virtual autopsy, including CT-guided biopsy, with conventional autopsy procedures in a paediatric population.
Foetuses, newborns, infants and children that are referred for autopsy at three different institutions associated with the University of Zurich will be eligible for recruitment. All bodies will be examined with a commercial CT and a 3 Tesla MRI scanner, and investigators will be blinded to the results of conventional autopsy. After cross-sectional imaging, CT-guided tissue sampling will be performed by a multifunctional robotic system (Virtobot) allowing for automated post-mortem biopsies. Virtual autopsy results will be classified with regards to the likely final diagnosis and major pathological findings and compared to the results of conventional autopsy, which remains the diagnostic gold standard.
This interdisciplinary study will determine whether virtual autopsy will narrow the gap in information between non-invasive and traditional autopsy procedures.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Stillbirth Newborn Death Sudden Infant Death | Procedure: Minimally invasive, virtual autopsy Procedure: Conventional autopsy | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 105 participants |
Allocation: | Non-Randomized |
Intervention Model: | Crossover Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Diagnostic |
Official Title: | Post-mortem Cross-sectional Imaging With Guided Biopsy; A Comparative Study With Conventional Autopsy in Foetuses, Neonates, Infants and Children |
Actual Study Start Date : | January 1, 2014 |
Actual Primary Completion Date : | July 31, 2018 |
Actual Study Completion Date : | August 31, 2018 |

Arm | Intervention/treatment |
---|---|
Experimental: Foetuses
|
Procedure: Minimally invasive, virtual autopsy
Post-mortem cross-sectional imaging with CT-guided biopsy
Other Name: Virtopsy Procedure: Conventional autopsy Other Name: Postmortem |
Experimental: Newborns
|
Procedure: Minimally invasive, virtual autopsy
Post-mortem cross-sectional imaging with CT-guided biopsy
Other Name: Virtopsy Procedure: Conventional autopsy Other Name: Postmortem |
Experimental: Children and adolescents
|
Procedure: Minimally invasive, virtual autopsy
Post-mortem cross-sectional imaging with CT-guided biopsy
Other Name: Virtopsy Procedure: Conventional autopsy Other Name: Postmortem |
- Percentage of cases for which virtual autopsy correctly identifies the cause of death and/or major pathological lesions [ Time Frame: 8 weeks ]The diagnoses established in both ways by the two independent teams will be compared, the autopsy results being the gold standard. The primary outcome will be the percentage of cases for which virtual autopsy correctly identifies the diagnostic category.
- Clinical indication [ Time Frame: 8 weeks ]Number of false positive and false negative results of virtual autopsy will be calculated for each organ system.
- MR Protocol [ Time Frame: 8 weeks ]To optimize a protocol for MR imaging examinations in deceased foetuses, neonates, infants and children
- Change in the ante-mortem diagnosis [ Time Frame: 8 weeks ]The proportion of cases, for which virtual autopsy leaded to a change in ante-mortem diagnosis, will be reported.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | up to 16 Years (Child) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion criteria:
- Stillborn infants ≥ 16 0/7 weeks of gestational age (GA)
- Live born infants ≥ 16 0/7 weeks GA until adolescents up to 16 years of age, who died of natural- and non-natural cause (trauma, homicide, suicide and intoxication).
Exclusion criteria:
- Deceased infants who are donors of organs
- Lack of parental consent

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01888380
Switzerland | |
University Hospital Zurich, Division of Neonatology | |
Zurich, ZH, Switzerland, 8091 | |
Division of obstetrics, University Hospital Zurich | |
Zurich, Switzerland | |
University Children's Hospital Zurich | |
Zurich, Switzerland | |
Zurich Institute for Forensic Medicine | |
Zurich, Switzerland |
Study Director: | Hans Ulrich Bucher, MD, Prof | University Hospital Zurich, Division of Neonatology | |
Principal Investigator: | Christoph Rüegger, MD | University Hospital Zurich, Division of Neonatology |
Responsible Party: | University of Zurich |
ClinicalTrials.gov Identifier: | NCT01888380 |
Other Study ID Numbers: |
Paediatric virtopsy |
First Posted: | June 27, 2013 Key Record Dates |
Last Update Posted: | January 11, 2021 |
Last Verified: | March 2020 |
Autopsy Minimally invasive Foetuses |
Newborns Children Adolescents |
Stillbirth Death Infant Death Sudden Infant Death Pathologic Processes |
Fetal Death Pregnancy Complications Female Urogenital Diseases and Pregnancy Complications Urogenital Diseases Death, Sudden |